Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021

Breast. 2021 Dec 13:S0960-9776(21)01018-3. doi: 10.1016/j.breast.2021.12.012. Online ahead of print.NO ABSTRACTPMID:34920925 | DOI:10.1016/j.breast.2021.12.012

Source: Breast - December 18, 2021 Category: Cancer & Oncology Authors: Dario Trapani Giuseppe Curigliano Source Type: research